Search clinical trials for: Cetuximab, Capecitabine

Total 4818 results

Dutch Colorectal Cancer Group
Sanofi; Roche Pharma AG; Koningin Wilhelmina Fonds; Immunicon

Completed

Cetuximab, Capecitabine, Oxaliplatin and Bevacizumab in Advanced Colorectal Cancer

Colorectal Cancer

Netherlands
King Faisal Specialist Hospital & Research Center

Completed

A Trial of Pre-Operative Chemoradiotherapy Using Capecitabine, Radiation & Cetuximab, in Rectal Cancer

Colon Rectal Cancer Duke Stage Stageval

Saudi Arabia
Sun Yat-sen University

Active, not recruiting

Cetuximab Plus Capecitabine as Maintenance Treatment in RAS and BRAF wt Metastatic Colorectal Cancer (C-CLASSIC)

Colorectal Cancer

China
Translational Genomics Research Institute
Eli Lilly and Company

Withdrawn

Study of Capecitabine and Cetuximab as First-Line Therapy in Patients With Metastatic Wild Type Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Colorectal Cancer

Metastatic Colorectal Cancer

United States
University of Medicine and Dentistry of New Jersey
Bristol-Myers Squibb; Rutgers Cancer Institute of New Jersey

Terminated

First-Line Capecitabine and Cetuximab for Metastatic Colorectal Ca in Elderly Patients

Colorectal Cancer

United States
Institute of Oncology Ljubljana

Unknown

Cetuximab (Erbitux®), Capecitabine and Radiotherapy in Neoadjuvant Treatment of Patients With Rectal Cancer (XERT)

Rectal Cancer

Slovenia
Peking University
Merck Sharp & Dohme LLC

Completed

A Study of Cetuximab(Erbitux) With Cisplatin and Capecitabine(Xeloda)as 1st Line Treatment in the Advanced Gastric Cancer (EXTRA)

Gastric Cancer

China
National University Hospital, Singapore

Unknown

A Study of Radiotherapy in Rectal Cancer Using Oxaliplatin, Capecitabine With or Without Cetuximab

Rectal Cancer

Singapore
Swiss Group for Clinical Cancer Research

Completed

Capecitabine and Oxaliplatin With or Without Cetuximab in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

Colorectal Cancer

Switzerland
Huazhong University of Science and Technology
The First Affiliated Hospital of Nanchang University; Henan Cancer Hospital; Hunan...

Unknown

A Single Arm, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Maintenance Treatment With Capecitabine Plus Cetuximab in Metastatic Colorectal Cancer

Colorectal Neoplasms

China
Wales Cancer Trials Unit
Cancer Research UK

Unknown

Cisplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients With Esophageal Cancer

Esophageal Cancer

United Kingdom
Abramson Cancer Center of the University of Pennsylvania
Bristol-Myers Squibb; Roche Pharma AG

Terminated

Capecitabine,Oxaliplatin & Erbitux Given Throughout Multi-Modal Therapy for Locally Advanced Rectal Adenocarcinoma

Rectal Cancer
Asan Medical Center

Completed

Study of XELOX With Cetuximab in Advanced Gastric Cancer

Gastric Cancer

Korea, Republic of
Dorte Nielsen

Completed

Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From Cholangiocarcinoma

Cholangiocarcinoma

Denmark
UNC Lineberger Comprehensive Cancer Center
Bristol-Myers Squibb; National Cancer Institute (NCI); Sanofi; Roche Pharma AG; National...

Completed

Oxaliplatin, Capecitabine, and Cetuximab in Treating Patients With Advanced Liver Cancer (NRR)

Liver Cancer

United States
National Cancer Center, Korea

Unknown

Preoperative Chemoradiotherapy With Cetuximab in Rectal Cancer (ERBIRIX)

Rectal Neoplasms | Neoadjuvant Treatment

Korea, Republic of
Royal Marsden NHS Foundation Trust

Unknown

Oxaliplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients Undergoing Surgery for High-Risk Rectal Cancer (EXPERT-C)

Colorectal Cancer

Spain, United Kingdom, Sweden
Ludwig-Maximilians - University of Munich
Sanofi; Merck Sharp & Dohme LLC; Pfizer; Hoffmann-La Roche

Completed

Cap/Iri Plus Cetuximab Compared to Cap/ox Plus Cetuximab in Patients With Metastatic Colorectal Cancer.

Metastatic Colorectal Cancer
Sun Yat-sen University

Recruiting

Efficacy and Safety of Triweekly Cetuximab in Combination With Capecitabine as First-line Maintenance Treatment for KRAS/BRAF Wild-type Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

China
City of Hope Medical Center
National Cancer Institute (NCI)

Terminated

Cetuximab and Capecitabine in Treating Patients With Metastatic Colorectal Cancer That Failed Irinotecan Treatment

Colorectal Cancer

United States
Tianjin Hemay Oncology Pharmaceutical Co., Ltd

Recruiting

A Phase Ⅲ Study of the Efficacy and Safety of Hemay022+Aromatase Inhibitor(AI) in Participants With ER+/HER2+ Advanced or Metastatic Breast Cancer (Fillful-03)

Breast Cancer

China
University College, London

Completed

Capecitabine, Irinotecan Hydrochloride, Cetuximab, and Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer (EXCITE)

Rectal Cancer

United Kingdom
Northwell Health

Terminated

Super-Selective Intraarterial Infusion of Cetuximab (Erbitux) With or Without Radiation Therapy for the Treatment of Unresectable Recurrent Squamous Cell Carcinoma of the Head and Neck

Carcinoma, Squamous Cell | Carcinoma, Squamous Cell of Head and Neck

United States
National Center for Tumor Diseases, Heidelberg

Terminated

Trial of Lapatinib Versus Lapatinib With Capecitabine in Her2+ Metastatic Gastro-Esophageal Cancer (GastroLap)

GastroEsophageal Cancer

Germany
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal Cancer

Colorectal Cancer

United States
Herbert Hurwitz
National Cancer Institute (NCI)

Completed

Capecitabine, Cetuximab, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer That Cannot Be Removed By Surgery

Colorectal Cancer

United States
Medical University of South Carolina

Completed

Cetuximab, Gemcitabine, and Oxaliplatin Followed By Surgery or External-Beam Radiation Therapy and Capecitabine in Treating Patients With Locally Advanced, Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery

Pancreatic Cancer

United States
Dr Anna Dorothea Wagner

Terminated

Combination Chemotherapy, Cetuximab and Radiation for Patients With Localized Gastric Cancer

Gastric Cancer

Switzerland
Austrian Breast & Colorectal Cancer Study Group
Hoffmann-La Roche; Merck Gesellschaft mbH, Austria

Completed

Preoperative Chemoradiation With Capecitabine and Cetuximab

Rectal Cancer

Austria
Swiss Group for Clinical Cancer Research

Terminated

Cetuximab for Elderly Patients With mCRC

Metastatic Colorectal Cancer

Switzerland
Merck KGaA, Darmstadt, Germany

Completed

Erbitux in Combination With Xeloda and Cisplatin in Advanced Esophago-gastric Cancer (EXPAND)

Gastric Cancer

Brazil, Bulgaria, Czech Republic, France, Italy, Korea, Republic of, Poland, Russian Federation, Spain, United Kingdom, Germany, China, Hungary, Romania, Japan, Hong Kong, Argentina, Austria, Belgium, Chile, Israel, Greece, Taiwan, Au... and more
Per Pfeiffer
Odense University Hospital; Aarhus University Hospital

Terminated

A Randomised Trial With Irinotecan, Cetuximab and Everolimus (ICE)Compared to Capecitabine and Oxaliplatin (CapOx) for Patients With Gemcitabin Resistant Pancreatic Cancer

Pancreatic Cancer

Denmark
University Hospital, Caen

Unknown

Anticancer Vigilance Of Cardiac Events (AVOCETTE) in Metastatic Colorectal Cancer (AVOCETTE)

Colorectal Cancer Metastatic

France
University of Colorado, Denver
Bristol-Myers Squibb; Sanofi

Terminated

Preoperative Capecitabine, Oxaliplatin, Cetuximab, and Radiation Therapy for Locally Advanced Esophageal Adenocarcinoma

Esophageal Adenocarcinoma

United States
Federation Francophone de Cancerologie Digestive

Recruiting

Randomised Study Evaluating Adjuvant Chemotherapy After Resection of Stage III Colonic Adenocarcinoma in Patients of 70 and Over (ADAGE)

Colonic Adenocarcinoma

France
NYU Langone Health
Bristol-Myers Squibb; Eli Lilly and Company

Completed

Cetuximab Plus Biweekly Capecitabine and Oxaliplatin in KRAS Wild Type Metastatic Colorectal Cancer

Neoplasm Metastasis | Colorectal Cancer

United States
Fox Chase Cancer Center

Terminated

Combination of Cetuximab, Capecitabine, and Oxaliplatin With or Without Bevacizumab

Colorectal Neoplasms

United States
Velindre NHS Trust

Unknown

Combination Chemotherapy With or Without Cetuximab as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer

Colorectal Cancer

United Kingdom, Ireland
Celgene

Active, not recruiting

A Study of CC-95251, a Monoclonal Antibody Directed Against SIRPα, in Participants With Advanced Solid and Hematologic Cancers

Neoplasms

United States, France, Australia, Canada, Italy, Korea, Republic of, Spain, United Kingdom
UNICANCER

Terminated

Radiation Therapy, Chemotherapy, and Cetuximab Followed by Surgery, Chemotherapy, and Cetuximab in Treating Patients With Locally Advanced or Metastatic Rectal Cancer That Can Be Removed by Surgery

Colorectal Cancer

France
Sun Yat-sen University
Chengdu Biostar Pharmaceuticals

Not yet recruiting

Utidelone Plus Capecitabine Versus Taxane Plus Capecitabine in HER2-negative Locally Advanced or Metastatic Breast Cancer

Breast Neoplasms | Locally Advanced or Metastatic Breast Cancer

China
Sumitomo Pharma America, Inc.

Completed

A Study of BBI608 in Adult Patients With Advanced Colorectal Cancer

Colorectal Cancer

United States
University Medical Center Groningen
UMC Utrecht; Erasmus Medical Center

Recruiting

Image Guided Surgery for Margin Assessment of Head and Neck Cancer Using Cetuximab-IRDye800CW cONjugate (ICON)

Head and Neck Squamous Cell Carcinoma | Margin Assessment

Netherlands
Charite University, Berlin, Germany

Completed

InductionChemo-Radio-Antibody-Treatment (ICRAT)

Squamous Cell Carcinoma of the Neck | Squamous Cell Carcinoma of the Head

Germany
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

Study Of Capecitabine Combined With Camrelizumab For Non-pCR TNBC With TLS After Neoadjuvant Chemoterapy

Breast Neoplasms

China
Hoffmann-La Roche

Completed

A Study of Capecitabine Rapid Disintegrating Tablets (RDT) Versus Commercial Xeloda in Patients With Solid Tumours

Breast Cancer, Colorectal Cancer

New Zealand, Australia, United Kingdom
Cheryl Pugh

Completed

Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal Cancer

Colorectal Cancer

United Kingdom, Cyprus
Amsterdam UMC, location VUmc
Radboud University Medical Center; University Medical Center Groningen

Terminated

Image Guided Treatment Optimization With Cetuximab for Patients With Metastatic Colorectal Cancer (IMPACT-CRC)

Metastatic Colorectal Cancer

Netherlands
West China Hospital
First Affiliated Hospital of Chongqing Medical University

Recruiting

First-line mCapOX+Cetuximab vs. mFOLFOX6+Cetuximab for Metastatic Left-sided CRC With Wild-type RAS/BRAF Genes (CAPCET)

Colo-rectal Cancer | Capecitabine | Cetuximab

China
Eben Rosenthal
National Cancer Institute (NCI)

Terminated

Cetuximab-IRDye 800CW and Intraoperative Imaging in Finding Pancreatic Cancer in Patients Undergoing Surgery

Pancreatic Adenocarcinoma

United States

3

Subscribe